News & Analysis on Clinical Trial Services & Contract Research And Development
The development of antimicrobial therapies and vaccines to treat biological terrorism threats such as anthrax and smallpox has been made easier by an automated colony counting system, which the company claim, significantly improves vaccine testing time.
Researchers from medical charity Cancer Research UK have discovered a new gene that protects against lung cancer, according to a study published today in the journal Proceedings of the National Academy of Sciences..
RNA interference (RNAi) therapeutics to combat human illnesses such as Huntingdon's disease, amyotrophic lateral sclerosis and hepatitis C are set to fuel the rapid growth in the RNAi research product market over the next year.
A new study has revealed that a commonly used asthma medication lost more than half its potency after being kept for just four hours in conditions akin to a mailbox on a hot day. This raises questions about the efficacy of mail-order drugs, and...
Caliper Life Sciences' LabChip technology continues to prove popular with large pharmaceutical companies as its third quarter financial results show a net loss that has more than halved from its 3Q 2003 performance.
UK drug discovery company Inpharmatica has raised £13.9 million (€19.9 million) in a third round stock financing with several top-tier biotechnology investors and says it will use the proceeds to progress its PharmaCarta platform technology.
Printing solutions specialist Zebra Technologies, a specialist in radio frequency identification (RFID) labels, has launched two new UHF (ultra high frequency) EPC (electronic product code) multi- protocol printer/encoders, the Zebra R110Xi and R170Xi.
A tiny pressure sensor already sold in the automotive industry could improve the efficacy of pumps used to deliver drugs from implanted reservoirs, according to one of the scientists behind the project.
In-Pharmatechnologist's periodic round up of personnel moves in the pharmaceutical sector includes a crop of new chief executives and senior managers across the pharmachem, drug development and manufacturing sectors.
Dutch chemicals group DSM is axing 200 jobs at its vitamin C plant in Dalry, Scotland in the next wave of a company-wide cost-cutting programme.